-
Mashup Score: 3Feature | What You Need to Know: Guidance For Clinicians on Dobutamine Shortage - American College of Cardiology - 2 year(s) ago
This document was developed by the ACC Heart Failure and Transplant Member Section, ACC Cardiovascular Team Section and University of Utah Health. Contributing authors: Maya Guglin, MD, FACC; Kristen Campbell, PharmD, FACC; Erin Fox, PharmD; Douglas Jennings, PharmD, FACC; Robert Page, PharmD; Kashif Saleem, MD; Dustin Spencer, PharmD; Barbara Wiggins, PharmD, FACC; Craig J. Beavers, PharmD,…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 9US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? - 2 year(s) ago
With stocks not expected to stabilize until late this year or early next, hospitals should be planning ahead, one expert says.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
We go from #contrast shortage to this: US #Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? @MinnowWalsh https://t.co/i8ttJiHNgl
-
-
Mashup Score: 1
Original Article from The New England Journal of Medicine — Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock
Source: New England Journal of MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Milrinone as Compared w/#Dobutamine in the Treatment of #CardiogenicShock Rebecca Mathew, MD, et al. U. Ottawa Heart Institute https://t.co/rF6ZKpdlJd @NEJM https://t.co/zZ5mvbdzxQ
-
-
Mashup Score: 10
Background Cardiogenic shock (CS) is associated with significant morbidity and mortality. The impact of beta-blocker (BB) use on patients who develop CS remains unknown. We sought to evaluate the clinical outcomes and hemodynamic response profiles in patients treated with BB in the 24 h prior to the development of CS. Methods Patients with CS enrolled in the DObutamine compaREd to MIlrinone trial…
Source: Critical CareCategories: Critical Care, Latest HeadlinesTweet-
#CritCare #OA Does #beta_blocker therapy before #cardiogenic_shock influence clinical #outcomes or #hemodynamic parameters? https://t.co/wD9fgZ929J #FOAMed #FOAMcc #BMC @ISICEM @jlvincen #Inotropes #Milrinone #Dobutamine https://t.co/YLrLVWkvTS
-
-
Mashup Score: 2
Original Article from The New England Journal of Medicine — Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
ICYMI: #Milrinone as Compared with #Dobutamine in the Treatment of #CardiogenicShock | NEJM https://t.co/cHUYnUihUI
-
-
Mashup Score: 5
Among patients with cardiogenic shock, there was no difference between the inotropic agents milrinone and dobutamine in clinical outcomes, according to findings published in The New England Journal of Medicine. For the randomized, double-blind DOREMI study, the researchers assigned 192 patients with cardiogenic shock to milrinone or dobutamine. The primary outcome was in-hospital death from any
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Among patients with cardiogenic shock, there was no difference between the inotropic agents #milrinone and #dobutamine in clinical outcomes, according to findings published in @NEJM @rebeccamathewmd @alumni_heart #CardioNews https://t.co/h8Gejnw5ai
-
Guidance For Clinicians on #Dobutamine Shortage - @ACCinTouch This document was developed by the ACC #HeartFailure and Transplant Member Section, #ACC Cardiovascular Team Section and @UUtah https://t.co/iEV71yhJFs @JACCJournals @DrJennHaythe @mmamas1973 @HeartOTXHeartMD @Hragy https://t.co/XZYB1Hyk8C